Research ExplorerPublicationsReal-world data on the effectiveness, safety and drug surviv...

Real-world data on the effectiveness, safety and drug survival of dupilumab: an analysis from the TREATgermany registry

  • Dora Stölzl
  • Nicole Sander
  • Annice Heratizadeh
  • Eva Haufe
  • Inken Harder
  • Susanne Abraham
  • Luise Heinrich
  • Andreas Kleinheinz
  • Andreas Wollenberg
  • Elke Weisshaar
  • Knut Schäkel
  • Konstantin Ertner
  • Franca Wiemers
  • Julia Wildberger
  • Margitta Worm
  • Ralph von Kiedrowski
  • Isaak Effendy
  • Andrea Asmussen
  • Matthias Augustin
  • Mario Pawlak
  • Michael Sticherling
  • Alexander Zink
  • Melanie Hilgers
  • Christiane Handrick
  • Sven Quist
  • Beate Schwarz
  • Petra Staubach-Renz
  • Magnus Bell
  • Sun-Hei Hong-Weldemann
  • Bernhard Homey
  • Jens-Joachim Brücher
  • Jochen Schmitt
  • Thomas Werfel
  • Stephan Weidinger
  • TREATgermany study group

Related Research units

Abstract

This interim analysis from the atopic dermatitis registry TREATgermany shows robust long-term efficacy, favourable safety and high persistence of dupilumab under real life conditions.

Bibliographical data

Original languageEnglish
ISSN0007-0963
DOIs
Publication statusPublished - 12.2022

Comment Deanary

© 2022 The Authors. British Journal of Dermatology published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists.

PubMed 35895855